The initiatives of EP-Link Co., Ltd. and EPS Corporation have been featured in a special report by Newsweek Country Reports titled “How Japan Is Accelerating Medical Innovation and Patient Access.”
The report highlights various efforts aimed at addressing challenges facing Japan’s healthcare system, including an aging population, shortages of healthcare professionals, drug lag, and drug loss, while strengthening the connections among research and development, clinical trials, and healthcare delivery.
EP-Link Co., Ltd. was featured for leveraging its nationwide network of medical institutions and Clinical Research Coordinators (CRCs), as well as its Patient LINK and SYNOV-R services. Through these initiatives, EP-Link supports more efficient patient recruitment, the digitalization of clinical trials, and improvements in the clinical trial environment and drug development process.
EPS Corporation was featured for its initiatives centered on EPS BIOPath, an integrated support service for domestic and international biotechnology and pharmaceutical companies seeking to enter the Japanese market. The service provides comprehensive support across regulatory strategy, development planning, biostatistics, project management, and clinical trial execution.
The initiatives of both companies were highlighted as examples of Japan’s efforts to accelerate patient access to innovative medicines and medical technologies. The EPS Group will continue to contribute to medical innovation by supporting the development of pharmaceuticals and medical devices, connecting innovation in Japan with the global healthcare community, and creating new value for patients worldwide.
Featured Article：
How Japan Is Accelerating Medical Innovation and Patient Access 
Related Links
Newsweek Country Reports ：Newsweek Country Reports – Newsweek
EP-Link Co., Ltd. ：Solutions｜EP-Link Co., Ltd.
EPS Corporation ：“EPS BIOPath”, EPS Launches a New End-to-End Support Service for Biotech Companies Entering Japan | NEWS | EPS